Bombinin-Like Peptide BLP-1

CAS No. 138220-00-5

Bombinin-Like Peptide BLP-1 ( )

Catalog No. M30452 CAS No. 138220-00-5

Bombinin-Like Peptide (BLP-1) is an antimicrobial peptide from Bombina species.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 259 Get Quote
10MG 409 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote

Biological Information

  • Product Name
    Bombinin-Like Peptide BLP-1
  • Note
    Research use only, not for human use.
  • Brief Description
    Bombinin-Like Peptide (BLP-1) is an antimicrobial peptide from Bombina species.
  • Description
    Bombinin-Like Peptide (BLP-1) is an antimicrobial peptide from Bombina species.(In Vitro):Bombinin-like peptides, BLP-1, 2, 3 share considerable, but not complete, homology with bombinin, an antimicrobial, hemolytic peptide first isolated from the skin of Bombina uariegata. The BLPs have been assayed for antibiotic and hemolytic activity and found to be more potent than magainin 2 (a related antimicrobial peptide from Xenopus laeuis) in their ability to kill bacteria.
  • Synonyms
  • Pathway
    GPCR/G Protein
  • Target
    Antibacterial
  • Recptor
    Bacterial
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    138220-00-5
  • Formula Weight
    2581
  • Molecular Formula
    C115H194N34O33
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

Gibson BW, et al. Bombinin-like peptides with antimicrobial activity from skin secretions of the Asian toad, Bombina orientalis. J Biol Chem. 1991 Dec 5;266(34):23103-11.
molnova catalog
related products
  • VXc-486

    VXc-486 (VXc486) is a novel inhibitor of gyrase B, potently inhibits multiple drug-sensitive isolates and drug-resistant isolates of Mycobacterium tuberculosis in vitro.

  • Taniborbactam

    Taniborbactam is a novel beta-lactamase inhibitor for the treatment of bacterial infections.

  • Gatifloxacin hydroch...

    A fourth-generation fluoroquinolone antibiotic that inhibits the bacterial DNA gyrase and topoisomerase IV.